
WuXi NextCODE Stock
Using genomic information to improve health
Sign up today and learn more about WuXi NextCODE Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About WuXi NextCODE Stock
WuXi NextCODE is a fully integrated contract genomics organization building the global standard platform for genomic data. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises using the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a WuXi Group company.
Investors
EDBI
Magic Leap, DataRobot, Nature's Fynd, Voyager Innovations, Welltok, Seismic, Inari, WuXi NextCODE, Sprinklr, Druva
Hercules Capital, Inc.
WuXi NextCODE, SingleStore, Druva, Udacity, Dashlane, JAB Broadband
Nexus Investment Ventures
NTT Finance
Riverwood Capital
WuXi NextCODE, Druva, Degreed, SecurityScorecard, Sauce Labs, ForgeRock, Greenhouse Software, Virtual Instruments
Sequoia Capital India
MobiKwik, OYO, Ola, Razorpay, WuXi NextCODE, Polygon Technology, Druva, Innovaccer, Twin Health, Beam
Funding History
October 2013 | $15.0M |
---|---|
May 2017 | $75.0M |
September 2017 | $165M |
November 2018 | $200M |
Management
CEO
Hannes Thor Smárason
President and Chief Scientific Officer
Jeffrey Gulcher
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase